Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Eric Hughes
Person

Eric Hughes

Tracked across 2 events · 14 articles · First seen Jul 07, 2026 · Last active Aug 19, 2026

Sentiment
0
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 0
Regulatory
FDA Accepts Teva Ecopipam NDA
Sun Pharma announced that the United States — Food and Drug Administration accepted its New Drug Application for ecopipam, a first-in-class D1 dopamine receptor antagonist for pediatric Rett syndrome, and granted Priority Review with a…
Impact: As Teva's Chief Medical Officer, Eric Hughes publicly commented on the milestone, emphasizing its importance to the company's strategy.
Aug 19, 2026 · 7 articles
3 0
Business
Teva advances TEV-408 to Phase 2b
Impact: As Chief Medical Officer, Eric Hughes expressed confidence in the IL-15 pathway and the program's potential.
Jul 07, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Eric Hughes live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.